Lonza completes acquisition of informatics solution developer MODA

Register for free to listen to this article
Listen with Speechify
BASEL, Switzerland—On May 18, Swiss pharmaceutical and life science product provider Lonza Group Ltd. completed its acquisition of MODA Technology Partners, a Wayne, Pa.-based developer of informatics solutions for the pharmaceutical and biotechnology quality manufacturing industries, for an undisclosed sum.

Lonza said the acquisition, initially announced May 12, continues the expansion of its Rapid Testing Solutions platforms, which enable same-day approaches to product and environmental testing, in both existing and new markets. Lonza's platforms currently include Endotoxin Detection, Informatics, Microbiology and Global Support.

Doug Danne, head of Lonza's Rapid Testing Solutions business unit, said in a statement that the company identified MODA's technology as a result of its own internal need to seek out automated tools that would help improve productivity and regulatory compliance. MODA's technology provides paperless, quality-control solutions for regulated, manufacturing processes. The technology can be applied to clinical trials, in vitro diagnostics, environmental and industrial process markets worldwide. The company bills its flagship software, MODA-EM, as a paperless quality-control microsolution that leverages mobile computing technology and advanced visualization tools for increased operational efficiency, improved quality and reduced costs.

The "MODA-EM informatics platform offered intelligent, real-time solutions and user-friendly trending tools that improved our return on investment," Danne stated. "Lonza provided a unique resource of being an expert user of the product, and we are excited to explore new applications of MODA's mobile data acquisition technology, both internally at Lonza, as well as for our external customers."

The implementation of MODA's technology will begin at Lonza's manufacturing locations globally. Going forward, customer sites will be fully supported through Lonza's Global Solutions Support team, offering hands-on installation, accelerated validation as well as training services.

"We are very excited to be part of the Lonza family," said MODA CEO Mike Desiderio in a statement. "Our shared vision for a comprehensive analytics platform is now a reality, providing the industry a clear path to enhanced compliance, improved efficiencies and expedited decision-making."

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

DDN July 2024 Magazine Issue

Latest Issue  

• Volume 20 • Issue 4 • July 2024

July 2024

July 2024 Issue